Keith Orford, Senior VP, CLINICAL DEVELOPMENT at Calithera Biosciences, Inc. (CALA), sold 2,120 shares at $18.31 ($39K) on 2017-07-17, disclosed to the SEC on 2017-07-19.
Scheduled sale ($39k) by Senior VP, CLINICAL DEVELOPMENT under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| CALA | SELL | 2020-12-18 | $15K | — | Filing → |
| CALA | SELL | 2020-02-24 | $24K | — | Filing → |
| CALA | SELL | 2019-12-26 | $18K | — | Filing → |